![](https://ally-bridge.com/wp-content/uploads/2022/05/BenevolentAI_Logo.jpg)
BenevolentAI
BenevolentAI is a clinical-stage drug discovery company seeking to combine artificial intelligence and machine learning with science to decipher complex disease biology, generate new insights and discover more effective medicines. The company’s computational R&D platform spans each step of the drug discovery process, with a focus on novel disease targets discovery.